Alpha 2.0
Login Register
» Articles » PMID: 34642607

Clinical Translation of Silica Nanoparticles

Overview
Journal Nat Rev Mater
Date 2021 Oct 13
PMID 34642607
Citations 69
Authors
Taskeen Iqbal Janjua
Yuxue Cao
Chengzhong Yu
Amirali Popat
Affiliations
Soon will be listed here.
Abstract

Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.

Citing Articles

Multi-stimuli-responsive pectin-coated dendritic mesoporous silica nanoparticles with Eugenol as a sustained release nanocarrier for the control of tomato bacterial wilt.

Guo X, Li H, Li Z, Cui Z, Ma G, Nassor A J Nanobiotechnology. 2025; 23(1):191.

PMID: 40055717 PMC: 11889862. DOI: 10.1186/s12951-025-03239-8.

Towards a New Dawn for Neuro-Oncology: Nanomedicine at the Service of Drug Delivery for Primary and Secondary Brain Tumours.

Khilar S, Dembinska-Kenner A, Hall H, Syrmos N, Ligarotti G, Plaha P Brain Sci. 2025; 15(2).

PMID: 40002469 PMC: 11852924. DOI: 10.3390/brainsci15020136.

A multistage drug delivery approach for colorectal primary tumors and lymph node metastases.

Yuan Y, Lin Q, Feng H, Zhang Y, Lai X, Zhu M Nat Commun. 2025; 16(1):1439.

PMID: 39920155 PMC: 11806101. DOI: 10.1038/s41467-025-56768-z.

Holistic Investigation of Graphene Quantum Dot Endocytosis.

Topkiran U, Valimukhametova A, Vashani D, Paul H, Dorsky A, Sottile O Small. 2025; 21(9):e2406095.

PMID: 39895235 PMC: 11878264. DOI: 10.1002/smll.202406095.

Exploring Gluconamide-Modified Silica Nanoparticles of Different Sizes as Effective Carriers for Antimicrobial Photodynamic Therapy.

Prieto-Montero R, Herrera L, Tejon M, Albaya A, Chiara J, Fanarraga M Nanomaterials (Basel). 2024; 14(24.

PMID: 39728518 PMC: 11728795. DOI: 10.3390/nano14241982.

References
1.
Anselmo A, Mitragotri S . Nanoparticles in the clinic: An update post COVID-19 vaccines. Bioeng Transl Med. 2021; 6(3):e10246. PMC: 8420572. DOI: 10.1002/btm2.10246. View
2.
Yang Y, Zhang M, Song H, Yu C . Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators. Acc Chem Res. 2020; 53(8):1545-1556. DOI: 10.1021/acs.accounts.0c00280. View
3.
Tan A, Eskandar N, Rao S, Prestidge C . First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen. Drug Deliv Transl Res. 2015; 4(3):212-21. DOI: 10.1007/s13346-013-0172-9. View
4.
Meola T, Abuhelwa A, Joyce P, Clifton P, Prestidge C . A safety, tolerability, and pharmacokinetic study of a novel simvastatin silica-lipid hybrid formulation in healthy male participants. Drug Deliv Transl Res. 2020; 11(3):1261-1272. DOI: 10.1007/s13346-020-00853-x. View
5.
Rastinehad A, Anastos H, Wajswol E, Winoker J, Sfakianos J, Doppalapudi S . Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc Natl Acad Sci U S A. 2019; 116(37):18590-18596. PMC: 6744844. DOI: 10.1073/pnas.1906929116. View